Unitedhealth Group Inc. (DE:UNH)
NYSE:UNH
UNH Stock Chart & Stats
€273.80
€4.40(0.87%)
At close: 4:00 PM EST
€273.80
€4.40(0.87%)
Day’s Range― - ―
52-Week Range€204.50 - €359.80
Previous CloseN/A
Volume49.00
Average Volume (3M)2.25K
Market Cap
€319.88B
Enterprise Value€395.29B
Total Cash (Recent Filing)€31.23B
Total Debt (Recent Filing)€77.92B
Price to Earnings (P/E)30.9
Beta-0.20
Next Earnings
Jul 16, 2026EPS Estimate
4.19Next Dividend Ex-DateN/A
Dividend Yield2.72%
Share Statistics
EPS (TTM)13.24
Shares Outstanding908,144,400
10 Day Avg. Volume1,926
30 Day Avg. Volume2,250
Financial Highlights & Ratios
PEG Ratio-1.62
Price to Book (P/B)3.19
Price to Sales (P/S)0.67
P/FCF Ratio18.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€351.92Price Target Upside28.53% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering23
EPS Forecast (FY)15.94
Revenue Forecast (FY)€384.52B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistent operating and free cash flow give UnitedHealth durable internal funding for investments, M&A discipline, share repurchases and dividends. Stable cash conversion (~0.82–0.89 historically) supports capital returns and resilience through medical-cost cycles, strengthening long-term financial flexibility.
Diversified Business Model With Optum UpsideA diversified model (UnitedHealthcare + Optum) reduces single-market exposure while Optum’s operational improvements, client wins and sizable AI investments create durable competitive advantages in care delivery, pharmacy services and analytics, driving higher-margin service growth over multi-year horizons.
Manageable Leverage And Solid Balance SheetModerate leverage and a strengthening equity base preserve financial flexibility for strategic capital allocation. A controlled debt profile supports continued investment in technology and clinical programs while keeping capacity for buybacks or opportunistic acquisitions without jeopardizing credit stability.
Bears Say
Membership ContractionSustained declines in membership reduce premium revenue scale and underwriting leverage, pressuring long-term revenue growth and margin recovery. Persistent member attrition, especially in Medicare/ACA cohorts, can limit pricing power and increase per-member fixed-cost absorption across administrative functions.
Margin And ROE CompressionMaterial step-down in ROE and compressed gross/operating/net margins signal reduced earnings efficiency. If elevated medical trend and cost pressures persist, sustained margin compression could limit cash flow growth, constrain reinvestment capacity, and slow return-to-target profitability absent structural cost or pricing improvements.
Regulatory And Legal Pressure, Medicaid Funding HeadwindsActive litigation and structural Medicaid funding shortfalls introduce multi-quarter regulatory and reimbursement risk. State-level investigations and adverse policy changes can reduce Medicaid profitability, increase compliance costs, and constrain margins in lower-reimbursed segments over the medium term.
UnitedHealth News
UNH FAQ
What was Unitedhealth Group Inc.’s price range in the past 12 months?
Unitedhealth Group Inc. lowest stock price was €204.50 and its highest was €359.80 in the past 12 months.
What is Unitedhealth Group Inc.’s market cap?
Unitedhealth Group Inc.’s market cap is €319.88B.
When is Unitedhealth Group Inc.’s upcoming earnings report date?
Unitedhealth Group Inc.’s upcoming earnings report date is Jul 16, 2026 which is in 30 days.
How were Unitedhealth Group Inc.’s earnings last quarter?
Unitedhealth Group Inc. released its earnings results on Apr 21, 2026. The company reported €6.251 earnings per share for the quarter, beating the consensus estimate of €5.685 by €0.566.
Is Unitedhealth Group Inc. overvalued?
According to Wall Street analysts Unitedhealth Group Inc.’s price is currently Undervalued.
Does Unitedhealth Group Inc. pay dividends?
Unitedhealth Group Inc. pays a Quarterly dividend of €2.004 which represents an annual dividend yield of 2.72%. See more information on Unitedhealth Group Inc. dividends here
What is Unitedhealth Group Inc.’s EPS estimate?
Unitedhealth Group Inc.’s EPS estimate is 4.19.
How many shares outstanding does Unitedhealth Group Inc. have?
Unitedhealth Group Inc. has 908,144,400 shares outstanding.
What happened to Unitedhealth Group Inc.’s price movement after its last earnings report?
Unitedhealth Group Inc. reported an EPS of €6.251 in its last earnings report, beating expectations of €5.685. Following the earnings report the stock price went up 8.358%.
Which hedge fund is a major shareholder of Unitedhealth Group Inc.?
Currently, no hedge funds are holding shares in DE:UNH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
UnitedHealth Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€351.92 (28.53% Upside)
€351.92 (28.53% Upside)
Blogger Sentiment
Bullish
DE:UNH Sentiment 70%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth €246.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Bullish
Bullish news 79%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
31.88%
12-Months-Change
Fundamentals
Return on Equity
12.40%
Trailing 12-Months
Asset Growth
0.92%
Trailing 12-Months
Company Description
Unitedhealth Group Inc.
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
UNH Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call portrayed a generally constructive and improving operational picture: the company delivered an earnings beat, modest revenue growth, improved medical care ratio, strong cash generation and clear early progress at Optum Health and Optum Rx driven by operational improvements and digital/AI initiatives. Management emphasized disciplined pricing, continued investments in AI (nearly $1.5B in 2026) and capital returns, while acknowledging known challenges such as membership contraction (including a large ACA decline), Medicaid funding pressure, persistently elevated medical trends, one-time seasonal and prior-year tailwinds, and regulatory uncertainties that could temper future performance. Overall, leadership signaled cautious optimism with continued focus on execution and margin recovery, but noted that meaningful second-quarter data and the back-half seasonality will be important to confirm sustainability.View all DE:UNH earnings summariesUNH Revenue Breakdown
78.70% Premiums
11.93% Products
8.50% Services
0.88% Investment and other income
UNH Stock 12 Month Forecast
Average Price Target
€351.92
▲(28.53% Upside)
Technical Analysis
Options Prices
Currently, No data available
---